Log In
Print
BCIQ
Print
Print this Print this
 

Defitelio, defibrotide

  Manage Alerts
Collapse Summary General Information
Company Jazz Pharmaceuticals plc
DescriptionSingle-stranded oligodeoxyribonucleotides derived from porcine mucosal DNA
Molecular Target Cathepsin G
Mechanism of ActionCathepsin G inhibitor
Therapeutic ModalityNucleic acid: Linear DNA
Latest Stage of DevelopmentMarketed
Standard IndicationLiver disease
Indication DetailsPrevent hepatic veno-occlusive disease (VOD); Prevent pediatric veno-occlusive disease (VOD); Prevent veno-occlusive disease (VOD) in adults; Treat and prevent hepatic veno-occlusive disease (VOD); Treat and prevent hepatic veno-occlusive disease (VOD) in hematopoietic stem-cell transplantation therapy in adults and children; Treat hepatic veno-occlusive disease (VOD) in hematopoietic stem-cell transplantation therapy in adults and children; Treat pediatric veno-occlusive disease (VOD); Treat severe veno-occlusive disease (VOD); Treat veno-occlusive disease (VOD)
Regulatory Designation U.S. - Expanded Access (Treat severe veno-occlusive disease (VOD));
U.S. - Fast Track (Prevent hepatic veno-occlusive disease (VOD));
U.S. - Orphan Drug (Treat and prevent hepatic veno-occlusive disease (VOD));
EU - Orphan Drug (Treat and prevent hepatic veno-occlusive disease (VOD));
EU - Standard Review (Treat and prevent hepatic veno-occlusive disease (VOD) in hematopoietic stem-cell transplantation therapy in adults and children);
Australia - Orphan Drug (Treat severe veno-occlusive disease (VOD))
Partner Link Healthcare; Valeant Pharmaceuticals International Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$1,000.0M

$1,000.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today